Cordis Cardiac & Vascular Institute

 

One step ahead in primary PCI: lessons from the STRATEGY, MULTISTRATEGY, TYPHOON and SESAMI trials
Published Date   10 Sep 2009

Panel:   Christian Spaulding, Marco Valgimigli, Carmine Musto
September 24, 2009, 12.30 – 13.30

Topics for discussion:
• What trends do these four trials show in terms of efficacy and safety of SES in AMI?
• How could these four trials influence the current clinical practice in AMI?
• What reasons would you have not to use a SES in AMI?
• Open/ unanswered questions on DES in AMI. Shortcomings from the four trials.
• Reaching a consensus on the use of SES in AMI

Refreshments: Buffet Lunch
Venue: Intercontinental Hotel, 888 Howard Street, San Francisco, USA
Intercontinental Ballroom A - (2 blocks from Moscone)
 

 

This site is published by Cordis Cardiac and Vascular Institute, a division of Johnson & Johnson Medical NV (CCVI), which is solely responsible for the content. It is intended for health care professionals from Europe, Middle-East, Africa and Canada. © CCVI 2011 All rights reserved.
Some documents on this site are stored in Adobe® PDF format and require Adobe® Reader® to view. Click here to download.